MyAverix Finance
IC · Healthcare
Alvotech (ALVO)
Drug Manufacturers - Specialty & Generic
Alvotech (ALVO) is listed on IC in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-24, reported market cap is $129.50B, P/E ratio is 18.00, net margin is -14.4%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for ALVO
Alvotech (ALVO) — FAQ
What is Alvotech's market cap?
Alvotech (ALVO) has a reported market cap of $129.50B (data as of 2026-05-24).
What is ALVO's P/E ratio?
The price-to-earnings (P/E) ratio for Alvotech (ALVO) is 18.00 (data as of 2026-05-24).
Does Alvotech pay a dividend?
Dividend yield is not available in the current snapshot for Alvotech (ALVO). Check the MyAverix Finance app for the latest dividend data.
What sector is Alvotech in?
Alvotech (ALVO) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is ALVO listed on?
ALVO is listed on IC.
What is Alvotech's net margin?
Alvotech (ALVO) reports a net margin of -14.4% (data as of 2026-05-24).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.